Semaglutide hydrogel could reduce diabetes shots to once a month
French researchers have developed a new drug delivery system that could cut the dosing schedule for type 2 diabetes and weight control...
top of page
Browse by category
Search
Gelesis’ hydrogel promotes weight loss and metabolic health by targeting the gut-liver axis
Weight loss resulting from Gelesis’ superabsorbent hydrogel treatment is not only a result of its space-occupying properties, the...
OMP begins first human trial of self-expanding hydrogel capsule Sirona
Oxford Medical Products (OMP) has initiated the first human trial of Sirona, its self-expanding hydrogel capsule which aims to deliver a...
Oxford Medical Products gains £2.5 million funding for weight-loss hydrogel technology
Oxford Medical Products has raised £2.5M in equity investment to conduct the first human trials of Sirona, its weight-loss platform....
NTU researchers use gel and infrared light to tackle obesity
Scientists at Nanyang Technological University, Singapore (NTU Singapore), have developed a new therapeutic approach to obesity and...
OMP receives €1.3 million for Sirona self-expanding hydrogel weight loss capsule
Oxford Medical Products (OMP) has raised €1.3 million to develop a safe and affordable weight loss capsule, which uses the same mechanism...
Gelesis gains European approval for PLENITY weight loss treatment
Gelesis, a biotechnology company developing a novel hydrogel platform technology to treat obesity and other chronic diseases related to...
Browse by tag
bottom of page